Ownership history in Clarius Group, LLC · 18 quarters on record
This page tracks every 13F SEC filing in which Clarius Group, LLC reported a position in NAUTILUS BIOTECHNOLOGY INC (NAUT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,209,646 | — | 0% | 0.13% | $2.4M | $1.95 |
| 2025 Q3 | ADDED | 1,209,646 | +149,186 | +14.1% | 0.06% | $1.0M | $0.85 |
| 2025 Q2 | ADDED | 1,060,460 | +193,874 | +22.4% | 0.04% | $769K | $0.73 |
| 2025 Q1 | ADDED | 866,586 | +230,054 | +36.1% | 0.05% | $746K | $0.86 |
| 2024 Q4 | UNCHANGED | 636,532 | — | 0% | 0.07% | $1.1M | $1.68 |
| 2024 Q3 | UNCHANGED | 636,532 | — | 0% | 0.13% | $1.8M | $2.85 |
| 2024 Q2 | ADDED | 636,532 | +16,661 | +2.7% | 0.11% | $1.5M | $2.34 |
| 2024 Q1 | ADDED | 619,871 | +22,102 | +3.7% | 0.13% | $1.8M | $2.94 |
| 2023 Q4 | UNCHANGED | 597,769 | — | 0% | 0.15% | $1.8M | $2.99 |
| 2023 Q3 | REDUCED | 597,769 | -203 | -0.0% | 0.18% | $1.9M | $3.16 |
As of 2025 Q4 — sorted by position size